Literature DB >> 10519671

Takayasu's arteritis with renovascular hypertension: results of surgical treatment.

M K Teoh1.   

Abstract

Renal artery stenosis caused by Takayasu's arteritis is an important cause of hypertension in young patients in the Far East. The role of surgery in Takayasu's arteritis is not as well-defined as in atherosclerosis or fibromuscular dysplasia. In this retrospective review, the author reports the results of 19 renal artery reconstructions in 12 young patients (median age 23.5 years, range 10-46 years) presenting with renovascular hypertension and Takayasu's arteritis, and discusses the different surgical options. The procedures performed included aortorenal bypass using vein (five), aortorenal bypass using polytetrafluoroethylene (PTFE) (eight), iliorenal bypass using vein (four), reimplantation of renal artery (one) and aortic replacement graft-renal bypass (one). Postoperatively, all 12 patients had a successful outcome with improved hypertension. There was no perioperative mortality, and complications included two early graft thrombosis and one late graft occlusion. These results support the view that surgical treatment for renovascular hypertension in Takaysu's disease is safe and effective.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10519671     DOI: 10.1016/s0967-2109(99)00050-2

Source DB:  PubMed          Journal:  Cardiovasc Surg        ISSN: 0967-2109


  2 in total

Review 1.  Acute thrombosis of a transplanted renal artery after gastric ulcer bleeding in a patient with a long-term well-functioning renal allograft: A case report and literature review.

Authors:  Chung-Kuan Wu; Jyh-Gang Leu; Cheng-Chun Wei; Shih-Chung Hsieh
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

2.  Hepatorenal bypass using autogenous, free internal iliac artery graft: An attractive alternative to revascularize the right kidney in Takayasu's disease.

Authors:  Nikhil Khattar; Sandeep Guleria; Sanjeev Sharma
Journal:  Indian J Urol       Date:  2012-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.